Weight loss drug candidate Zealand Pharma rises 17% on trial results

Vials on the Wegovy line at Novo Nordisk A/S’s production facilities in Hillerod, Denmark, on Friday, March 8, 2024.

Bloomberg | Bloomberg | Getty Images

LONDON – Shares of Denmark’s Zealand Pharma rose to a record high on Friday after an early-stage trial of its weight-loss drug challenger returned positive results.

Gains had cooled to around 17% by 2pm London time, after exceeding more than 23% in morning trading.

Leave a Comment